Key collaborator of jaguar health joint venture magdalena biosciences receives prestigious alzheimer's association award

Magdalena biosciences, a joint venture formed by jaguar and filament health, is focused on developing novel prescription psychoactive plant-based medicines for various mental health indications san francisco, ca / accesswire / august 20, 2024 / jaguar health, inc. (nasdaq:jagx) ("jaguar") today announced that eduardo zimmer, ph.d., a key collaborator with magdalena biosciences ("magdalena"), the joint venture formed by jaguar and filament health corp. (otcqb:flhlf)(cboe ca:fh)(fse:7qs) to develop novel, natural prescription psychoactive medicines derived from plants for mental health indications, is the 2024 recipient of the prestigious blas frangione early career achievement award.
JAGX Ratings Summary
Quant
JAGX Quant Ranking
Sector
Industry
Quant Rating
Quant Score